Log In
BCIQ
Print this Print this
 

AAV LK19 FANCC (ABO-301)

Also known as: AAV FANCC

  Manage Alerts
Collapse Summary General Information
Company Abeona Therapeutics Inc.
DescriptionAdeno-associated virus (AAV) vector LK19 (AAV LK19) that delivers the Fanconi anemia complementation group C (FANCC) gene
Molecular Target Fanconi anemia complementation group C (FANCC)
Mechanism of ActionGene therapy
Therapeutic ModalityGene therapy: Viral vector: Adeno-associated virus (AAV)
Latest Stage of DevelopmentPreclinical
Standard IndicationAnemia
Indication DetailsTreat Fanconi anemia
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

2

0

0

0


 Deals Details
Get a free BioCentury trial today